Industry reports
Editor highlights

Biopharmaceutical Industry in Denmark: Market Research Reports, Statistics and Analysis

You might be interested in: biosimilar, protein, bioprocessing, more »

» View Public Reports

19 reports

The Danish Enzyme Sector

  • Industry report
  • December 2012
  • 30 pages

... Method that may reduce the amount of enzyme used and increase enzymatic productivity is to recycle the enzymes [10,11]. Conceptually, the assumption is that by recovering the active enzymes from ...

Biopharmaceutical Market in Denmark

  • Industry report
  • July 2009
  • 9 pages

... As inactivated enzyme had no effect. The effective enzyme concentration was determined over a period of 72 h, as by then all the tested concentrations inhibited biofilm formation maximally. The effective ...

Company Report: Biopharmaceutical in The United States, Japan and Denmark for Year 2013

  • Company report
  • September 2013
  • 10 pages
  • by Corporation

... Maintained 3 maximizing the value of ofatumumab 1st line cll patients inappropriate for flrabine-based therapy breakthrough therapy designation eu & us applications to expand label in 1st line cll ...

Company Report: Biopharmaceutical in Denmark and The United States for Year 2012

  • Company report
  • March 2012
  • 29 pages
  • by Corporation

... Respectively. Inclacumab (rg1512) inclacumab (ro4905417) is a fully human monoclonal antibody that is designed to selectively inhibit p- selectin, an adhesion molecule that is believed to play a pivotal role ...

Company Report: Biopharmaceutical in Denmark and The United States for Year 2010

  • Company report
  • December 2010
  • 5 pages
  • by Corporation

... Continuing to progress our pre-clinical and clinical pipeline. 2011 Operating expenses include approximately dkk 80 million related to zalutumumab and represents a full 12 months of genmab announces ...

Genmab A/S - Investment Analysis, November 2010

  • Company report
  • November 2010
  • 6 pages

... The start of a phase iii study of single agent ofatumumab compared to single agent rituximab in patients with follicular non-hodgkin S lymphoma (nhl) that has relapsed at least 6 months after completion ...

Company Report: Biopharmaceutical in Denmark for Year 2010

  • Company report
  • August 2010
  • 16 pages
  • by Corporation

... biopharmaceutical ingredients 2% sales and markets 2010 was a very strong year from a sales perspective. High demand in the enzyme business resulted in double-digit organic sales growth for novozymes. Total sales ...

Company Report: Biopharmaceutical in The United States and Denmark for Year 2010

  • Company report
  • June 2010
  • 35 pages

... With cll that is refractory to flrabine and alemtuzumab under the trade name arzerra. Ofatumumab is a novel human monoclonal antibody which targets a part of the cd20 molecule encompassing an epitope ...

BioPorto A/S - Investment Analysis, May 2010

  • Company report
  • May 2010
  • 14 pages

... The test in a testing format other than elisa and concerning access to bioporto S ip and other technology within the apc-pci area. The antibody portfolio revenues generated by the antibody portfolio ...

Search in Biopharmaceutical Industry

» Purchase Premium Reports (From $ 75 - $ 3 835)

8 reports
Epitomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Epitomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Epitomics, Inc. (Epitomics) is a biotechnology company, based in the US. The company designs, develops and distributes monoclonal antibody technology (RabMab). Its antibody products are secondary ...

Global Vaccine Market To 2017 - Market Size, Growth, An ...

June 2013 $ 2 488

Sports Nutrition Market Overview In Denmark

May 2013 $ 898

Nvo - Kalundborg New Biopharmaceutical Production Facil ...

April 2013 $ 75

Enzymes In Drug Manufacturing

March 2011 $ 3 835

Danisco A/s Swot

February 2011 $ 175

Biopharmaceutical: Growth Hormone Deficiency (ghd)

November 2010 $ 2 000

Danisco

October 2009 $ 75

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.